{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:05:51Z","timestamp":1790521551488,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1124\/dmd.114.057968","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T00:42:34Z","timestamp":1395880954000},"page":"1067-1073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Differential Effects of Rifampin and Ketoconazole on the Blood and Liver Concentration of Atorvastatin in Wild-Type and Cyp3a and Oatp1a\/b Knockout Mice"],"prefix":"10.1016","volume":"42","author":[{"given":"Jae H.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Plise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Messick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.114.057968_bib1","first-page":"755","article-title":"Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin","volume":"26","author":"Black","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.057968_bib2","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1021\/mp4001348","article-title":"Evaluating the in vitro inhibition of UGT1A1, OATP1B1, OATP1B3, MRP2, and BSEP in predicting drug-induced hyperbilirubinemia","volume":"10","author":"Chang","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.114.057968_bib3","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1124\/dmd.107.015677","article-title":"P-glycoprotein has differential effects on the disposition of statin acid and lactone forms in mdr1a\/b knockout and wild-type mice","volume":"35","author":"Chen","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.057968_bib4","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.1074\/jbc.M004968200","article-title":"Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6","volume":"276","author":"Cui","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.114.057968_bib5","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1177\/0091270011422815","article-title":"Disposition of atorvastatin, rosuvastatin, and simvastatin in oatp1b2\u2212\/\u2212 mice and intraindividual variability in human subjects","volume":"52","author":"DeGorter","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.114.057968_bib6","unstructured":"FDA (2012) FDA Guidance for Industry: Drug Interaction Studies \u2014 Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations."},{"key":"10.1124\/dmd.114.057968_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0090-9556(24)15274-9","article-title":"Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression","volume":"27","author":"Gibbs","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.057968_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.clpt.2006.09.010","article-title":"Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart","volume":"80","author":"Grube","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.057968_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP\/SLC21 family: phylogenetic classification as OATP\/SLCO superfamily, new nomenclature and molecular\/functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1124\/dmd.114.057968_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/dmd.113.054783","article-title":"Utility of Oatp1a\/1b-knockout and OATP1B1\/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein","volume":"42","author":"Higgins","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.057968_bib11","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1053\/j.gastro.2006.02.034","article-title":"Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics","volume":"130","author":"Ho","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.114.057968_bib12","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1021\/mp300108c","article-title":"Organic anion-transporting polypeptides 1a\/1b control the hepatic uptake of pravastatin in mice","volume":"9","author":"Iusuf","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.114.057968_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.114.057968_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/01.fpc.0000170913.73780.5f","article-title":"Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells","volume":"15","author":"Kameyama","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.114.057968_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0009-9236(98)90023-6","article-title":"Effect of itraconazole on the pharmacokinetics of atorvastatin","volume":"64","author":"Kantola","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.057968_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/gast.2001.21176","article-title":"Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver","volume":"120","author":"Kullak-Ublick","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.114.057968_bib17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/sj.clpt.6100038","article-title":"Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers","volume":"81","author":"Lau","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.057968_bib18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1124\/jpet.105.093088","article-title":"Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems","volume":"316","author":"Lau","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.114.057968_bib19","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1124\/dmd.105.009076","article-title":"Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism","volume":"34","author":"Lau","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.057968_bib20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2165\/00003495-199753050-00011","article-title":"Atorvastatin: a review of its pharmacology and therapeutic potential in the management of hyperlipidaemias","volume":"53","author":"Lea","year":"1997","journal-title":"Drugs"},{"key":"10.1124\/dmd.114.057968_bib21","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1345\/aph.1A481","article-title":"Rhabdomyolysis with concurrent atorvastatin and diltiazem","volume":"36","author":"Lewin","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1124\/dmd.114.057968_bib22","series-title":"Package insert","year":"2012"},{"key":"10.1124\/dmd.114.057968_bib23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.5414\/CPP48798","article-title":"Atorvastatin-induced acute elevation of hepatic enzymes and the absence of cross-toxicity of pravastatin","volume":"48","author":"Liu","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.057968_bib24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/clpt.2011.142","article-title":"Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study","volume":"90","author":"Maeda","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.057968_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1124\/dmd.107.017814","article-title":"Investigation of the inhibitory effects of various drugs on the hepatic uptake of fexofenadine in humans","volume":"36","author":"Matsushima","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.057968_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1067\/mcp.2000.110537","article-title":"Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin","volume":"68","author":"Mazzu","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.114.057968_bib27","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1172\/JCI108204","article-title":"Hepatic organic anion uptake in the rat","volume":"56","author":"Scharschmidt","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.114.057968_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/FPC.0b013e328342f5b1","article-title":"Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity","volume":"21","author":"Schwarz","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.114.057968_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/bdd.1823","article-title":"Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption","volume":"34","author":"Shitara","year":"2013","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.114.057968_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1172\/JCI59526","article-title":"Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver","volume":"122","author":"van de Steeg","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.114.057968_bib31","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1172\/JCI42168","article-title":"Organic anion transporting polypeptide 1a\/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs","volume":"120","author":"van de Steeg","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.114.057968_bib32","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1172\/JCI33435","article-title":"Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism","volume":"117","author":"van Herwaarden","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.114.057968_bib33","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1124\/dmd.109.029397","article-title":"Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam","volume":"37","author":"van Waterschoot","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.057968_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/dmd.109.030254","article-title":"Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans","volume":"38","author":"Watanabe","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.114.057968_bib35","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/jpet.108.146647","article-title":"Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans","volume":"328","author":"Watanabe","year":"2009","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624114304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624114304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.114.057968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:35:01Z","timestamp":1739907301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624114304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0090955624114304"],"URL":"https:\/\/doi.org\/10.1124\/dmd.114.057968","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Effects of Rifampin and Ketoconazole on the Blood and Liver Concentration of Atorvastatin in Wild-Type and Cyp3a and Oatp1a\/b Knockout Mice","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.114.057968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}